Star Silver Pharmaceutical

Star Silver Pharmaceutical is an integrated pharmaceutical enterprise based in China, founded in 1994 and headquartered in Shenzhen. The company focuses on the research, manufacturing, and marketing of high-quality proprietary medicines, chemical drugs, and healthcare products across multiple therapeutic areas including cardiovascular, gastroenterology, and pediatrics. Its flagship product, Maizhiling (sodium aescinate), is a market leader in China for the treatment of chronic venous insufficiency and hemorrhoids. The company operates multiple production bases and research centers, maintaining a significant commercial presence throughout the Chinese domestic market.